These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 900789)

  • 1. [Effect of Corynebacterium parvum on various viral infections in the mouse].
    Geniteau M; Quero AM; German A
    Ann Pharm Fr; 1977; 35(5-6):181-7. PubMed ID: 900789
    [No Abstract]   [Full Text] [Related]  

  • 2. Induction of resistance to ectromelia virus infection by corynebacterium parvum in murine peritoneal macrophages.
    Cohen DA; Bubel HC
    J Reticuloendothel Soc; 1983 Jan; 33(1):35-46. PubMed ID: 6300395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immunological activities of components isolated from Corynebacterium parvum in mice injected with polyoma tumor cells.
    Tomecki J; Mara M
    Neoplasma; 1987; 34(1):15-22. PubMed ID: 3031518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of nonspecific immune stimulation with Corynebacterium parvum and polidin on the Ehrlich ascites tumor growth.
    Todoruţiu C; Rişcă R; Daicoviciu D; Mulea R
    Morphol Embryol (Bucur); 1982; 28(1):77-83. PubMed ID: 6461826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lasting rejection of mammary adenocarcinoma cell tumors in DBA-2 mice with intratumor injection of killed Corynebacterium parvum.
    Likhite VV; Halpern BN
    Cancer Res; 1974 Feb; 34(2):341-4. PubMed ID: 4810906
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of Corynebacterium parvum on the class and subclass of antibody produced in the response of different strains of mice to sheep erythrocytes.
    Warr GW; James K
    Immunology; 1975 Mar; 28(3):431-42. PubMed ID: 1092609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection by Corynebacterium parvum against tumour cells injected intravenously.
    Milas L; Mujagić H
    Rev Eur Etud Clin Biol; 1972 May; 17(5):498-500. PubMed ID: 4648182
    [No Abstract]   [Full Text] [Related]  

  • 8. The effect of Corynebacterium parvum on T cell dependent tumor regression.
    McBride WH; Peters LJ; Mason KA; Barrow G
    J Reticuloendothel Soc; 1980 Feb; 27(2):151-8. PubMed ID: 6965725
    [No Abstract]   [Full Text] [Related]  

  • 9. The long-standing history of Corynebacterium parvum, immunity, and viruses.
    Palmieri B; Vadalà M; Roncati L; Garelli A; Scandone F; Bondi M; Cermelli C
    J Med Virol; 2020 Nov; 92(11):2429-2439. PubMed ID: 32472706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antitumor effect of Corynebacterium parvum on C3H mouse bearing MH-134 tumor].
    Nakamura K; Miwa H; Hashimoto O; Inoue T; Orita K
    Gan To Kagaku Ryoho; 1982 Jul; 9(6):1046-51. PubMed ID: 7184438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Immunotherapy with Corynebacterium parvum in experimental influenza virus infections and mixed infections in mice].
    Denys A; Kowalska M; Szydłowska T; Białek J
    Pol Tyg Lek; 1986 May; 41(19):619-23. PubMed ID: 3763446
    [No Abstract]   [Full Text] [Related]  

  • 12. [Mechanism of the antitumor immunity potentiated by anaerobic Corynebacterium parvum].
    Miyata H
    Fukuoka Igaku Zasshi; 1983 Jul; 74(7):451-69. PubMed ID: 6662469
    [No Abstract]   [Full Text] [Related]  

  • 13. Administration of interleukin-10 at the time of priming protects Corynebacterium parvum-primed mice against LPS- and TNF-alpha-induced lethality.
    Smith SR; Terminelli C; Denhardt G; Narula S; Thorbecke GJ
    Cell Immunol; 1996 Nov; 173(2):207-14. PubMed ID: 8912878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in normal mice.
    Wolmark N; Levine M; Fisher B
    J Reticuloendothel Soc; 1974 Oct; 16(4):252-7. PubMed ID: 4455907
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of the age of the mouse on the action of Corynebacterium parvum in inhibiting the growth of 2 syngenetic tumors].
    Mazureka C; Stiffel C; Chalvet H; Biozzi G
    C R Seances Acad Sci III; 1981 Oct; 293(4):225-8. PubMed ID: 6794870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
    Fisher B; Wolmark N; Coyle J
    J Natl Cancer Inst; 1974 Dec; 53(6):1793-801. PubMed ID: 4471644
    [No Abstract]   [Full Text] [Related]  

  • 17. Enhanced resistance of Corynebacterium parvum-treated mice to infection by bacteria.
    Adlam C; Broughton ES; Scott MT
    J Med Microbiol; 1972 Feb; 5(1):Pvii. PubMed ID: 4336739
    [No Abstract]   [Full Text] [Related]  

  • 18. Suppressive effects of Corynebacterium parvum on primary and secondary antibody responses in mice.
    Ansell JD; Trail KN; McDougall CM; Inchley CJ
    J Reticuloendothel Soc; 1983 Oct; 34(4):311-21. PubMed ID: 6620257
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proceedings: Immunotherapy of Moloney sarcoma virus tumours in mice with Corynebacterium parvum.
    Hamilton DN; Bell PR
    Br J Surg; 1974 Apr; 61(4):321. PubMed ID: 4832648
    [No Abstract]   [Full Text] [Related]  

  • 20. Mechanisms of antitumor action of Corynebacterium parvum: the generation of cell-mediated tumor specific immunity.
    Tuttle RL; North RJ
    J Reticuloendothel Soc; 1976 Sep; 20(3):197-208. PubMed ID: 978659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.